(Q82294729)
Statements
Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE) (English)
Axel Grothey
Mary M Sugrue
David M Purdie
Wei Dong
Eric Hedrick